Relationship between TSH Levels and the Advanced Lipoprotein Profile in the Brazilian Longitudinal Study of Adult Health (ELSA–Brasil)
暂无分享,去创建一个
I. Benseñor | A. Goulart | P. Lotufo | I. Santos | M. Blaha | R. Santos | M. Sommer Bittencourt | Steven R. Jones | K. Kulkarni | P. Toth | Érique José F.Peixoto de Miranda | Marcio Sommer Bittencourt | S. Jones
[1] R. Jain. Associations between the levels of thyroid hormones and lipid/lipoprotein levels: Data from National Health and Nutrition Examination Survey 2007-2012. , 2017, Environmental toxicology and pharmacology.
[2] P. Clopton,et al. Lipoprotein(a)-cholesterol levels estimated by vertical auto profile correlate poorly with Lp(a) mass in hyperlipidemic subjects: Implications for clinical practice interpretation of Lp(a)-mediated risk. , 2016, Journal of clinical lipidology.
[3] R. Dullaart,et al. Low normal thyroid function as a determinant of increased large very low density lipoprotein particles. , 2015, Clinical biochemistry.
[4] R. Dullaart,et al. Low-Normal Thyroid Function and Novel Cardiometabolic Biomarkers , 2015, Nutrients.
[5] F. Guillén-Grima,et al. A cross‐sectional study of the association between circulating TSH level and lipid profile in a large Spanish population , 2013, Clinical endocrinology.
[6] Maria Inês Schmidt,et al. Rotinas de organização de exames e entrevistas no centro de investigação ELSA-Brasil , 2013 .
[7] S. Taquette,et al. Consulta ginecológica bajo la óptica de estudiantes de educación secundaria en Rio de Janeiro, RJ , 2013 .
[8] B. Biondi,et al. Subclinical thyroid disease , 2012, The Lancet.
[9] S. Klein,et al. Subclinical hypothyroidism and hyperthyroidism have opposite effects on hepatic very-low-density lipoprotein-triglyceride kinetics. , 2012, The Journal of clinical endocrinology and metabolism.
[10] P. Rosário,et al. TSH reference values for adult Brazilian population. , 2010, Arquivos brasileiros de endocrinologia e metabologia.
[11] J. Franklyn,et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. , 2010, JAMA.
[12] M. Alberiche,et al. Thyrotropin levels and their relationship with cardiovascular risk factors in the island of Gran Canaria, Spain. Implications of lowering the upper reference limit of thyrotropin stimulating hormone , 2009, Journal of endocrinological investigation.
[13] B. Biondi,et al. The clinical significance of subclinical thyroid dysfunction. , 2008, Endocrine reviews.
[14] L. Vatten,et al. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. , 2007, European journal of endocrinology.
[15] K. Kulkarni,et al. Cholesterol profile measurement by vertical auto profile method. , 2006, Clinics in laboratory medicine.
[16] R. Jorde,et al. Serum lipid levels in relation to serum thyroid‐stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study , 2006, Journal of internal medicine.
[17] A. Miyauchi,et al. Disturbed metabolism of remnant lipoproteins in patients with subclinical hypothyroidism. , 2004, The American journal of medicine.
[18] W. Pearson,et al. Subclinical Hypothyroidism and the Risk of Hypercholesterolemia , 2004, The Annals of Family Medicine.
[19] J. Franklyn,et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.
[20] A. Miyauchi,et al. Serum concentrations of remnant‐like particles in hypothyroid patients before and after thyroxine replacement , 2003, Clinical endocrinology.
[21] A. Tsatsoulis,et al. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine. , 2003, Thyroid : official journal of the American Thyroid Association.
[22] W Harry Hannon,et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). , 2002, The Journal of clinical endocrinology and metabolism.
[23] H. Hecht,et al. Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification. , 2001, The American journal of cardiology.
[24] T. Tzotzas,et al. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. , 2000, Thyroid : official journal of the American Thyroid Association.
[25] S. Fortmann,et al. Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [NHANES III], 1988-1994). , 2000, The American journal of cardiology.
[26] H. Kraemer,et al. Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994. , 1998, JAMA.
[27] M. Alevizaki,et al. High serum cholesterol levels in persons with 'high-normal' TSH levels: should one extend the definition of subclinical hypothyroidism? , 1998, European journal of endocrinology.
[28] L. Braverman,et al. Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text , 1991 .
[29] M. Carvalho,et al. [Participants recruitment in ELSA-Brasil (Brazilian Longitudinal Study for Adult Health)]. , 2013, Revista de saude publica.
[30] I. Benseñor,et al. [Routines of organization of clinical tests and interviews in the ELSA-Brasil investigation center]. , 2013, Revista de saude publica.
[31] E. Aquino,et al. Practice of Epidemiology Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): Objectives and Design , 2012 .